HIGH RATE OF MORBID CENTRAL LINE ASSOCIATED COMPLICATIONS DURING TREATMENT WITH DOSE-ADJUSTED R-EPOCH THERAPY FOR NON-HODGKIN LYMPHOMA
Reagan, P., David, R., Baran, A., Kelly, J., Loh, K., Casulo, C., Barr, P., Friedberg, J.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_193
Date:
June, 2017
File:
PDF, 85 KB
english, 2017